Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17063023rdf:typepubmed:Citationlld:pubmed
pubmed-article:17063023lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:17063023lifeskim:mentionsumls-concept:C0008196lld:lifeskim
pubmed-article:17063023lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:17063023lifeskim:mentionsumls-concept:C0017243lld:lifeskim
pubmed-article:17063023lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:17063023pubmed:issue6lld:pubmed
pubmed-article:17063023pubmed:dateCreated2006-10-25lld:pubmed
pubmed-article:17063023pubmed:abstractTextEvidence on the caries-preventive effect of chlorhexidine (CHX) among high-risk children is inconclusive, possibly because obscured by fluoride exposure. We investigated the effect of CHX among initially 3-year-old subjects whose baseline d(3)ft was = 0 and whose only regular fluoride exposure came from toothpaste. The subjects were assigned to three groups: high-risk test (HRT, n = 70), high-risk control (HRC, n = 71), and low-risk control (LRC, n = 70). Risk classification was based on salivary mutans streptococcal levels (MS, </>or=1.0 x 10(5) cfu/ml). Basic measures (oral hygiene, dietary counselling every 4 months) were given to all groups. HRT also underwent CHX gel applications for 3 consecutive days at 3-month intervals for 15 months. Eighteen months after baseline d(3)ft increments and proportions of children with d(3)ft increment >or=1 (%d(3)ft increment >or=1) among all groups were assessed. Anti-MS effect on high-risk children and caries-preventive effect on all children were statistically analysed by residual change analysis (MS), non-parametric tests and logistic regression analysis (caries). No differences were found between the groups in basic programme compliance. CHX significantly reduced MS levels. %d(3)ft increment >or=1 and mean d(3)ft increments were 34.3%, 0.56 (HRT), 32.4%, 0.54 (HRC) and 11.4%, 0.11 (LRC), with HRT/HRC values statistically significantly higher than LRC values and no significant difference between HRT and HRC. HRT children were not less likely to show new lesions than HRC children (OR = 1.09; 95% confidence interval 0.54-2.19), while high-risk children were 4 times more likely to show new lesions than low-risk children (OR = 3.71; 95% confidence interval 1.53-9.03). CHX gel applications showed moderate anti-MS effect but negligible caries-preventive effect.lld:pubmed
pubmed-article:17063023pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:languageenglld:pubmed
pubmed-article:17063023pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:citationSubsetDlld:pubmed
pubmed-article:17063023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17063023pubmed:statusMEDLINElld:pubmed
pubmed-article:17063023pubmed:issn0008-6568lld:pubmed
pubmed-article:17063023pubmed:authorpubmed-author:HausenHHlld:pubmed
pubmed-article:17063023pubmed:authorpubmed-author:PettiSSlld:pubmed
pubmed-article:17063023pubmed:issnTypePrintlld:pubmed
pubmed-article:17063023pubmed:volume40lld:pubmed
pubmed-article:17063023pubmed:ownerNLMlld:pubmed
pubmed-article:17063023pubmed:authorsCompleteYlld:pubmed
pubmed-article:17063023pubmed:pagination514-21lld:pubmed
pubmed-article:17063023pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:meshHeadingpubmed-meshheading:17063023...lld:pubmed
pubmed-article:17063023pubmed:year2006lld:pubmed
pubmed-article:17063023pubmed:articleTitleCaries-preventive effect of chlorhexidine gel applications among high-risk children.lld:pubmed
pubmed-article:17063023pubmed:affiliationG. Sanarelli Department of Public Health Sciences, La Sapienza University, Rome, Italy. stefano.petti@uniroma1.itlld:pubmed
pubmed-article:17063023pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17063023pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17063023lld:pubmed